NCT02354508 - Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 8, 2018

Study Completion Date

September 27, 2018

Conditions

Acromegaly

Interventions

DRUG

Pasireotide LAR

Pasireotide 40 mg and 60 mg. Pasireotide 20 mg which was allowed for dose decrease in case of adverse event.

Trial Locations (50)

1085

Novartis Investigative Site, Budapest

1200

Novartis Investigative Site, Brussels

1431

Novartis Investigative Site, Sofia

2650

Novartis Investigative Site, Edegem

3000

Novartis Investigative Site, Leuven

6720

Novartis Investigative Site, Szeged

10126

Novartis Investigative Site, Torino

10990

Novartis Investigative Site, Pulau Pinang

16132

Novartis Investigative Site, Genova

20122

Novartis Investigative Site, Milan

20162

Novartis Investigative Site, Milan

25030

Novartis Investigative Site, Besançon

30029

Novartis Investigative Site, Nîmes

34098

Novartis Investigative Site, Istanbul

34270

Novartis Investigative Site, Durango

34899

Novartis Investigative Site, Pendik / Istanbul

35128

Novartis Investigative Site, Padua

35340

Novartis Investigative Site, Izmir

41380

Novartis Investigative Site, Kocaeli

44130

Novartis Investigative Site, Guadalajara

44800

Novartis Investigative Site, Saint-Herblain

49933

Novartis Investigative Site, Angers

51092

Novartis Investigative Site, Reims

54511

Novartis Investigative Site, Vandœuvre-lès-Nancy

56124

Novartis Investigative Site, Pisa

60126

Novartis Investigative Site, Ancona

62502

Novartis Investigative Site, Wilayah Persekutuan

69677

Novartis Investigative Site, Bron

76031

Novartis Investigative Site, Rouen

80131

Novartis Investigative Site, Napoli

90127

Novartis Investigative Site, Palermo

100730

Novartis Investigative Site, Beijing

510080

Novartis Investigative Site, Guangzhou

610041

Novartis Investigative Site, Chengdu

700127

Novartis Investigative Site, Iași

C1180AAX

Novartis Investigative Site, CABA

C1428AQK

Novartis Investigative Site, CABA

B7602CBM

Novartis Investigative Site, Mar del Plata

21941-590

Novartis Investigative Site, Rio de Janeiro

57-7

Novartis Investigative Site, Floridablanca

Unknown

Novartis Investigative Site, Bogotá

02990

Novartis Investigative Site, Mexico City

1349 019

Novartis Investigative Site, Lisbon

4099-001

Novartis Investigative Site, Porto

4200-319

Novartis Investigative Site, Porto

011863

Novartis Investigative Site, Bucharest

06560

Novartis Investigative Site, Ankara

EC1A 7BE

Novartis Investigative Site, London

NG7 2UH

Novartis Investigative Site, Nottingham

PL6 8DH

Novartis Investigative Site, Plymouth